Role of epidermal growth factor in the expression of A431 cancer cell protease and red blood cell cytotoxicity.
The role of epidermal growth factor in the regulation of the proteolytic and RBC cytolytic activity of the A431 cancer cell line has been evaluated using our previously described gelatin/polyacrylamide electrophoretic assay and tumor-induced RBC cytolysis assay, respectively. A431 cells maintained in 10% fetal bovine serum were actively cytolytic for RBC (release index, 53.0 +/- 2.9%), whereas serum-starved cells maintained in serum-free medium were not cytolytic for RBC. RBC cytotoxicity was restored by adding as little as 3.4 pM epidermal growth factor to the serum-deprived cells. The RBC cytolytic stimulating activity of epidermal growth factor could be mimicked by the metal chelating agent 1,10-phenanthroline, suggesting a possible role for calcium ions in the action of epidermal growth factor and proteases. An enriched cell membrane preparation of A431 cells was also cytolytic for RBC but was unaffected by metal chelating agents. RBC-induced cytotoxicity was inhibited by the protease inhibitor leupeptin. Gelatin substrate gels of enriched A431 cell membrane preparations and serum-free supernatants revealed a pattern of high- and low-molecular-weight proteases that were stimulated by metal chelators and inhibited by leupeptin. The activity of these proteases appears to be regulated by epidermal growth factor by a process that may involve divalent cations.
DiStefano
J F
JF
Department of Research, Veterans Administration Medical Center, Northport, New York 11768.
Cotto
C A
CA
Lane
B
B
Hagag
N
N
D002294:Carcinoma, Squamous Cell / Q000201:enzymology* / Q000503:physiopathology; D004492:Edetic Acid / Q000494:pharmacology; D004591:Electrophoresis, Polyacrylamide Gel; D004815:Epidermal Growth Factor / Q000494:pharmacology*; D066246:ErbB Receptors / Q000502:physiology; D004912:Erythrocytes / Q000187:drug effects* / Q000473:pathology; D006801:Humans; D008970:Molecular Weight; D010447:Peptide Hydrolases / Q000032:analysis*; D014176:Protein Biosynthesis; D014107:Tosyllysine Chloromethyl Ketone / Q000494:pharmacology; D014407:Tumor Cells, Cultured
D014107:Tosyllysine Chloromethyl Ketone; D004815:Epidermal Growth Factor; D004492:Edetic Acid; D066246:ErbB Receptors; D010447:Peptide Hydrolases